What Doctors Don't Tell YouMS: A treatment too far
A drug which could cause suicidal depression has been licenced by the American Food and Drug Administration to treat multiple sclerosis. ...
Berlex, which makes Betaseron (interferon beta-1b), has issued a warning regarding the drug’s adverse effects on the liver. Used to slow the progression of multiple sclerosis, the drug can cause autoimmune hepatitis, leading to kidney failure, and...
What we term "multiple sclerosis" doesn't really exist as a recognizable entity. Although the main problem is damage to the myelin sheath, symptoms vary so widely that the end result is a collect ...
Although medicine is finally beginning to acknowledge the role of what we eat in making us ill, the hidden factor in illness is how well we digest it. A few pioneers like our panellist nutritional ...
The cause of MS is still a mystery. Many viruses have been strongly suspected, particularly the measles virus (Arch Neurol, 1990; 47(7):743-6). If this proves right, it may have significant impl ...
The potential link between the hepatitis B vaccine and multiple sclerosis has led the French government to suspend vaccinations in schools, much to the consternation of pro vaccination groups. ...
SLE is difficult to diagnose and even more difficult to treat. Many of the treatments currently administered to sufferers of SLE are nothing more than a shot in the dark. Since SLE can manifest i ...
The latest findings of the University of Calgary in Canada about how the mercury in your dental fillings can make you ill. ... ...
Interferon, hailed as offering "a new era" in the treatment of multiple sclerosis (MS), could actually be making patients suicidal, doctors fear. ...
